2.A method for reducing alkaline phosphatase (ALP) in a subject suffering from primary sclerosing cholangitis (PSC), comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising berberine ursodeoxycholate (BUDCA). 3.A method for red...